Asset Details
Do you wish to reserve the book?
Self-emulsifying Drug Delivery System for Praziquantel with Enhanced Ex Vivo Permeation
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Self-emulsifying Drug Delivery System for Praziquantel with Enhanced Ex Vivo Permeation
Do you wish to request the book?
Self-emulsifying Drug Delivery System for Praziquantel with Enhanced Ex Vivo Permeation
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Self-emulsifying Drug Delivery System for Praziquantel with Enhanced Ex Vivo Permeation
2023
Overview
Purpose
In this work, praziquantel (PZQ) was incorporated into self-emulsifying drug delivery system (SEDDS) formulations to demonstrate that the increased apparent solubility and dissolution rate enhance intestinal permeation.
Methods
Solubility measurements of PZQ were performed in lipid excipients and hydrophilic substances; ternary phase diagrams were constructed with the excipients in which PZQ showed increased solubility. SEDDS formulations were characterized by globule size, the polydispersity index, zeta potential, the self-emulsification time, and morphology by scanning and transmission electron microscopy. The formulations were evaluated by performing in vitro dissolution profiles and permeation profiles in an ex vivo model.
Results
Four SEDDS formulations were identified that increased the apparent solubility of praziquantel by 60–150 times. The dispersion sizes obtained were < 350 nm, with polydispersity index values < 0.3, dispersion times < 60 s, and zeta potential values < −25 mV. A notable increase in the PZQ dissolution rate was obtained compared with the reference drug product. The permeation profiles were adjusted to a first-order kinetic model, obtaining an apparent absorption rate constant (K
ab
) up to 18 times higher for SEDDS formulations than for PZQ powder, while the apparent permeability (P
app
) and the effective intestinal permeability (P
eff
) values increased up to 18 times for SEDDS formulations compared with PZQ powder.
Conclusion
The incorporation of PZQ into a SEDDS increases its apparent solubility and dissolution rate, changes that significantly enhance the processes of intestinal permeability. This behavior can be applied to support formulations of drugs belonging to class IV of the biopharmaceutical classification system.
Publisher
Springer US,Springer Nature B.V
